Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$81.88

-0.17 (-0.21%)

17:19
06/18/17
06/18
17:19
06/18/17
17:19

Eli Lilly granted Orphan designation for pediatric colitis treatment

The FDA has granted Eli Lilly Orphan designation for its "humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin-23" product in the treatment of ulcerative colitis in pediatric patients. The designation was granted June 15. Reference Link

LLY Eli Lilly
$81.88

-0.17 (-0.21%)

06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/07/17
FBCO
06/07/17
NO CHANGE
Target $38
FBCO
Outperform
ASCO meeting highlights pressure on Pfizer cancer assets, says Credit Suisse
Credit Suisse analyst Vamil Divan said he came away from the ASCO meeting feeling like positive progress by competitors is increasing the pressure on Pfizer's (PFE) cancer assets, specifically pointing to positive data for Roche's (RHHBY) Alecensa, Johnson & Johnson's (JNJ) Zytiga and Eli Lilly's (LLY) abemaciclib. Additionally, competition in the immune-oncology and PARP spaces will make it more challenging for Pfizer to gain traction, added Divan. He keeps an Outperform rating on Pfizer, citing valuation and its dividend yield, but he has concerns about its upcoming patent expirations and growth products.
06/12/17
LEER
06/12/17
NO CHANGE
Target $90
LEER
Outperform
Eli Lilly price target lowered to $90 from $93 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Eli Lilly (LLY) to $90 to reflect reduced sales forecasts for baricitinib, an oral JAK1/2 inhibitor to treat rheumatoid arthritis which the company collaborates with Incyte (INCY). Following AbbVie's (ABBV) positive Phase 3 data last week for its JAK1 inhibitor upadacitinib, Fernandez dropped his U.S. peak sales estimate for baricitinib by more than 50% to $400M and pushed out his U.S. launch time to 2020 from 2018. The analyst keeps an Outperform rating on Lilly shares.
06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Eli Lilly has positive read through from J&J data, says SunTrust
SunTrust analyst John Boris says that data for Johnson & Johnson's (JNJ) Invokana for diabetes represented a best-case scenario for Eli Lilly (LLY). J&J's drug "significantly reduced the combined risk of cardiovascular death, myocardial infarction and nonfatal stroke in diabetes patients at risk for or with a history of CV diseases," and its efficacy on CV death is positive for the SGLT-2 class, to which Eli Lilly's Jardiance also belongs, according to the analyst. But the data leaves Jardiance, which reduced CV death by a statistically significant 38% versus Invokana's non-significant 13%, as the best in the class, wrote the analyst, who reiterates a $101 price target and a Buy rating on Eli Lilly.

TODAY'S FREE FLY STORIES

MSFT

Microsoft

$83.72

1.19 (1.44%)

, AAPL

Apple

$173.14

3.16 (1.86%)

06:07
11/22/17
11/22
06:07
11/22/17
06:07
Periodicals
Microsoft's Skype removed from Apple, Android China app stores, Reuters says »

Microsoft's (MSFT)…

MSFT

Microsoft

$83.72

1.19 (1.44%)

AAPL

Apple

$173.14

3.16 (1.86%)

GOOG

Alphabet

$1,034.49

16.11 (1.58%)

GOOGL

Alphabet Class A

$1,050.30

15.64 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

  • 18

    Mar

MNTX

Manitex

$8.27

0.18 (2.23%)

06:06
11/22/17
11/22
06:06
11/22/17
06:06
Conference/Events
Manitex management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CYD

China Yuchai

$24.85

0.27 (1.10%)

06:04
11/22/17
11/22
06:04
11/22/17
06:04
Hot Stocks
China Yuchai receives first order from BAIC Group for passenger vehicle engines »

China Yuchai announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KW

Kennedy Wilson

$19.40

0.3 (1.57%)

06:02
11/22/17
11/22
06:02
11/22/17
06:02
Hot Stocks
Kennedy Wilson acquires apartment community in Greater Bellevue for $135M »

Kennedy Wilson has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$18.85

0.23 (1.24%)

05:55
11/22/17
11/22
05:55
11/22/17
05:55
Hot Stocks
KBR JV awarded FEED contract for Absheron Field in Azerbaijan »

KBR announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CRM

Salesforce

$108.80

1.43 (1.33%)

05:52
11/22/17
11/22
05:52
11/22/17
05:52
Downgrade
Salesforce rating change  »

Salesforce downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GG

Goldcorp

$13.23

-0.05 (-0.38%)

05:49
11/22/17
11/22
05:49
11/22/17
05:49
Downgrade
Goldcorp rating change  »

Goldcorp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNO

Terreno Realty

$37.74

0.74 (2.00%)

05:46
11/22/17
11/22
05:46
11/22/17
05:46
Upgrade
Terreno Realty rating change  »

Terreno Realty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

PAAS

Pan American Silver

$15.20

0.22 (1.47%)

05:42
11/22/17
11/22
05:42
11/22/17
05:42
Upgrade
Pan American Silver rating change  »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

CBRL

Cracker Barrel

$150.79

-6.41 (-4.08%)

05:41
11/22/17
11/22
05:41
11/22/17
05:41
Downgrade
Cracker Barrel rating change  »

Cracker Barrel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$8.22

-1.03 (-11.14%)

05:39
11/22/17
11/22
05:39
11/22/17
05:39
Recommendations
Vipshop analyst commentary  »

Vipshop price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NJR

New Jersey Resources

$43.80

-0.5 (-1.13%)

05:35
11/22/17
11/22
05:35
11/22/17
05:35
Upgrade
New Jersey Resources rating change  »

New Jersey Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBPB

Potbelly

$12.15

-0.15 (-1.22%)

05:31
11/22/17
11/22
05:31
11/22/17
05:31
Recommendations
Potbelly analyst commentary  »

Potbelly shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$108.80

1.43 (1.33%)

05:29
11/22/17
11/22
05:29
11/22/17
05:29
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

YNDX

Yandex

$34.28

0.57 (1.69%)

05:28
11/22/17
11/22
05:28
11/22/17
05:28
Hot Stocks
Yandex appoints Greg Abovsky as COO »

Yandex announced changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$21.39

-0.42 (-1.93%)

05:26
11/22/17
11/22
05:26
11/22/17
05:26
Downgrade
Mallinckrodt rating change  »

Mallinckrodt downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

05:25
11/22/17
11/22
05:25
11/22/17
05:25
General news
FX Action: The dollar has perked up »

FX Action: The dollar…

SIG

Signet Jewelers

$52.79

-23.05 (-30.39%)

05:22
11/22/17
11/22
05:22
11/22/17
05:22
Recommendations
Signet Jewelers analyst commentary  »

Signet Jewelers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

05:19
11/22/17
11/22
05:19
11/22/17
05:19
Recommendations
Axalta Coating analyst commentary  »

Nippon could bid as much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

, AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

05:16
11/22/17
11/22
05:16
11/22/17
05:16
Hot Stocks
Axalta Coating confirms takeover talks with Nippon Paint »

Axalta Coating Systems…

AXTA

Axalta Coating

$33.87

0.33 (0.98%)

AKZOY

AkzoNobel

$30.57

0.085 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLOG

Rand Logistics

$0.59

0.016 (2.80%)

05:15
11/22/17
11/22
05:15
11/22/17
05:15
Hot Stocks
Rand Logistics to be acquired by American Industrial Partners »

Rand Logistics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$52.20

-0.3 (-0.57%)

05:12
11/22/17
11/22
05:12
11/22/17
05:12
Hot Stocks
Scientific Games acquires 11.6M ordinary shares of NYX Gaming »

Scientific Games…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$90.19

-2.88 (-3.09%)

05:12
11/22/17
11/22
05:12
11/22/17
05:12
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

TEDU

Tarena

$13.36

-2.53 (-15.92%)

05:10
11/22/17
11/22
05:10
11/22/17
05:10
Downgrade
Tarena rating change  »

Tarena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.34 (1.54%)

05:07
11/22/17
11/22
05:07
11/22/17
05:07
Recommendations
HP Inc. analyst commentary  »

HP Inc. target raised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.